Nitric oxide induced damage and preventive effect of curcumin and quercetin on buffalo brain cystatin

Current Proteomics

Volumn 9, Issue 1, 2012, Pages 9-17

  Amin, Fakhra ^a   Bano, Bilqees ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Curcumin; Nitric oxide; Purification of Buffalo brain cystatin; Quercetin; Thiol proteinases inhibitor

Indexed keywords

CURCUMIN; CYSTATIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PAPAIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BUFFALO; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; ENZYME MODIFICATION; FLUORESCENCE SPECTROSCOPY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

MAMMALIA;

EID: 84858396134     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016412799746227     Document Type: Article

References (50)

1. Uddin, S. and Ahmad, S. Dietary antioxidants protection against oxidative stress. Biochem. Educ., 1995, 23, 2-7.
2. Halliwell, B.; Murcia, M.A.; Chirico, S. and Aruoma, O.I. Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit. Rev. Food Sci. Nutr., 1995, 35(1-2), 7-20.
3. Papas, A. M. Determination of antioxidants status in human. Lipids, 1996, 31, l77-182.
4. Albina, J. E. and Reichner, J. S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev., 1998, 17(1), 39-53.
5. Commenges, D.; Scotet, V.; Renaud, S.; Jacqmin-Gadda, H.; Barberger-Gateau. P. and Dartigues, J.F. Intake of flavonoids and risk of dementia. Eur. J. Epidemiol., 2000, 16(4), 357-363.
6. Eckert, A.; Keil, U.; Marques, C.A.; Bonert, A.; Frey, C.; Schüssel, K. and Müller, W.E. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem. Pharmacol., 2003, 66(8), 1627-1634.
7. Barja, G. Free radicals and aging. Trends. Neurosci., 2004, 27(10), 595-600.
8. Blankenvoorde, M.; Brand, H.; Henskens, Y.; Veerman, E. and Amerongen, A. (2000). Protease inhibitors in health and disease control-medical and industrial aspects. In Plants. Michaud D. http://www.eurekah.com; accessed December, 2001.
9. Ghafourifar, P. and Cadenas, E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci., 2005, 26(4), 190-195.
10. Virginia, H.; Sarah, L.E.; Rachel, J.S.; Nathaniel, T.; Joseph, S.; Adam, E. and Cecilia, G. Mitochondrial nitric-oxide synthase: Role in pathophysiology IUBMB Life, 2003, 55(10&11), 599-603.
11. Bredt, D.S. and Snyder, S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem., 1994, 63, 175-195.
12. Tran, M.H.; Yamada, K.; Nakajima, A.; Mizuno, M.; He, J.; Kamei, H. and Nabeshima, T. Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction. Mol. Psychiatry, 2003, 8(4), 407-412.
13. Thiyagarajan, M.; Kaul, C.L. and Sharma, S.S. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol., 2004, 142(5),899-911.
14. Torreilles, F.; Salman-Tabcheh, S.; Guérin, M. and Torreilles, J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev., 1999, 30(2), 153-163.
15. Butterfield, D.A.; Howard, B.J. and LaFontaine, M.A. Brain oxidative stress in animal models of accelerated aging and the agerelated neurodegenerative disorders, Alzheimer's disease and Huntington's disease. Curr. Med. Chem., 2001, 8(7), 815-828.
16. Kahl, K.G.; Zielasek, J.; Uttenthal, L.O.; Rodrigo, J.; Toyka, K.V. and Schmidt, H.H. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J. Neurosci. Res., 2003, 73(2), 198-205.
17. Klatt, P. and Lamas, S. Regulation of protein function by Sglutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem., 2000, 267(16), 4928-4944.
18. Clancy, R.M. and Abramson, S.B. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med., 1995, 210(2), 93-101.
19. Arora, R.B.; Kapoor, V.; Basu, N. and Jain, A.P. Antiinflammatory studies on Curcuma longa (turmeric). Indian J. Med. Res., 1971, 59(8), 1289-1295.
20. Negi, P.S.; Jayaprakasha. G.K.; Jagan Mohan Rao, L. and Sakariah, K.K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J. Agric. Food Chem., 1999, 47(10), 4297-4300.
21. Bourne, K.Z.; Bourne, N.; Reising, S.F. and Stanberry, L.R. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral. Res., 1999, 42(3), 219-226.
22. Apisariyakul, A.; Vanittanakom, N. and Buddhasukh, D.; Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J. Ethnopharmacol., 1995, 49(3), 163-169.
23. Kawamori, T.; Lubet, R.; Steele, V.E.; Kelloff, G.J.; Kaskey, R.B.; Rao, C.V. and Reddy, B.S. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/ progression stages of colon cancer. Cancer Res., 1999, 59(3), 597-601.
24. Itthipanichpong, C.; Ruangrungsi, N.; Kemsri, W. and Sawasdipanich, A. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J. Med. Assoc. Thai., 2003, 86 (Suppl 2), S299-S309.
25. Park, E.J.; Jeon, C.H.; Ko, G.; Kim, J. and Sohn, D.H. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol., 2000, 52(4), 437-440.
26. Shukla, P.K.; Khanna, V.K.; Khan, M.Y. and Srimal, R.C. Protective effect of curcumin against lead neurotoxicity in rat. Hum. Exp. Toxicol., 2003, 22(12), 653-658.
27. Iqbal, M.; Sharma, S.D.; Okazaki, Y.; Fujisawa, M. and Okada. S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol., 2003, 92(1), 33-38.
28. Murota, K. and Terao, J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys., 2003, 417(1), 12-17.
29. Hollman, P.C. and Katan, M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother., 1997, 51(8), 305-310.
30. Balazs, L. and Leon, M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res., 1994, 19(9), 1131-1137.
31. Ansari, M.A.; Abdul, H.M.; Joshi, G.; Opii, W.O. and Butterfield, D.A. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J. Nutr. Biochem., 2009, 20(4), 269-275.
32. Bouktaib, M.; Atmani, A. and Rolando, C.; Regio-and stereoselective synthesis of the major metabolite of quercetin, quercetin-3-O-b-D-glucuronide. Tetrahedron Lett., 2002, 43, 6263-6266.
33. Amin, F.; Khan, A.; Rizvi, S.J. and Bano, B. Purification and characterizaion of buffalo brain cystatin. Prot. Pept. Lett., 2011, 18, 210-218.
34. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S. and Tannenbaum, S.R. Analysis of nitrate, nitrite and 15n nitrate in biological fluids. Anal. Biochem., 1982, 126, 131-138.
35. Marcocci, L.; Maguire, J.J.; Droy-Lefaix, M.T. and Packer, L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun., 1994, 201(2), 748-755.
36. Royer, C.A.; Methods In Molecular Biology: Protein Stability And Folding: Theory and Practice, Edited By B. A Shirley: Human Press Inc. Totowa, NJ,1995, Vol. 40; pp. 65-67.
37. Mann, C.J.; Royer, C.A. and Matthews, C.R. Tryptophan replacements in the trp aporepressor from Escherichia coli: probing the equilibrium and kinetic folding models. Protein Sci., 1993, 2(11), 1853-1861.
38. Kunitz, M. Crystalline soybean trypsin inhibitors. J. Gen. Physiol., 1947, 30, 291-310.
39. Davies, K.J. and Delsignore, M.E. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J. Biol. Chem., 1987, 15, 262(20), 9908-9913.
40. Davies, K.J. Protein damage and degradation by oxygen radicals. I. general aspects. J. Biol. Chem., 1987, 15, 262(20), 9895-9901.
41. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA, 2004, 101(12), 4003-4008.
42. Pryor, W. A.; Houk, K.N.; Foote, C.S.; Fukuto, J.M.; Ignarro, L.J.; Squadrito, G.L. and Davies, K.J. Free radical biology and medicine: it's a gas, man!. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2006, 291(3), 491-511.
43. Khan, M. S. and Bano, B. Purification, characterization and kinetics of thiol protease inhibitor from goat (Capra hircus) lung. Biochemistry (Mosc)., 2009, 74(7), 781-788.
44. Sigfrid, L.A.; Cunningham, J.M.; Beeharry, N.; Lortz, S.; Tiedge, M.; Lenzen, S.; Carlsson, C. and Green, I.C. Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells. J. Mol. Endocrinol., 2003, 31(3), 509-518.
45. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M. and Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39(1), 44-84.
46. Calabrese, V.; Butterfield, D.A. and Stella, A.M. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem., 2003, 52(4), 177-181.
47. Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A. and Cole, G. M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280(7), 5892-5901.
48. Bernstein, H.G.; Kirschke, H.; Wiederanders, B.; Pollak, K.H.; Zipress, A. and Rinne, A.; The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. Mol. Chem. Neuropathol., 1996, 27(3), 225-247.
49. Jensson, O.; Pálsdóttir, A.; Thorsteinsson, L.; Arnason, A.; Abrahamson, M.; Olafsson, I. and Grubb, A. Cystatin C mutation causing amyloid angiopathy and brain hemorrhage. Biol. Chem. Hoppe Seyler., 1990, 371(Suppl), 229-232.
50. Shannon, P.; Pennacchio, L.A.; Houseweart, M.K.; Minassian, B.A. and Myers, R.M. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. J. Neuropathol. Exp. Neurol., 2002, 61(12), 1085-1091.